OncoSil Medical Limited (OSL.AX)
Delivers radioactive implants to treat pancreatic cancer directly inside tumors.
1.11+0.08%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+0.0%
The outlook
OncoSil Medical is trading above both its 50- and 200-day moving averages, showing positive near-term momentum. Analyst consensus leans buy with an average rating of 2.0, and the stock sits in the lower-to-middle portion of its 52-week range. Overall market data currently reflects a bullish lean.
What’s behind the score
Analyst consensusBuy — 2.0 avg
Price trendAbove its 50- & 200-day averages
52-week range43% of the way from its 52-week low to high
Market cap
$34.3M
52-wk high
2.09
52-wk low
0.37
50-day avg
0.82
200-day avg
0.83
Trailing P/E
—